Sponsor Pipeline

Wei Zhang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07154082 Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for… Hepatocellular Carcinoma (HCC) Recruiting
Disease Areas
Liver Cancer (1)
Get alerts when Wei Zhang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free